# Leica Biosystems and Sectra partner for FDA clearance of digital pathology solution

Leica Biosystems and Sectra announced a collaboration to seek a combined 510(k) clearance from the FDA for an integrated clinical digital pathology solution.

- Type: Partnership
- Announced: 2019-12-02
- Where: United States
- Status: announced
- Products: digital pathology solution, Aperio AT2 DX scanner
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Leica Biosystems GmbH](https://endata.com/companies/19457.md) (partner)
- [Sectra](https://endata.com/companies/43660.md) (partner)

## Sources

- [newswire.ca](https://www.newswire.ca/fr/news-releases/leica-biosystems-and-sectra-partner-to-pursue-fda-clearance-for-an-integrated-clinical-digital-pathology-solution-850715456.html), 2019-12-02: "Leica Biosystems and Sectra announce a collaboration to seek a combined 510(k) clearance from the U.S. Food & Drug Administration."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.